课题基金 / 基金详情

Analysis of expression pattern of the gene which is related to the radiation sensitivity in urothelial cancer and its clinical application

Analysis of expression pattern of the gene which is related to the radiation sensitivity in urothelial cancer and its clinical application
尿路上皮癌放射敏感性相关基因表达模式分析及临床应用
批准号:
15390482
负责人:
SHINOHARA Nobuo
金额:
$5.12万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2003
资助国家:
日本
项目状态:
已结题
起止时间:
2003 至 2004

项目摘要

项目成果

SHINOHARA Nobuo的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
From the present project, the following results were obtained.1.Initially, we evaluated radiation sensitivity in the nude mice transplanted with human bladder cancer cell lines. Utilizing this model, we set up the radiation exposure condition (single time irradiation of 5 Gy) and confirmed that tumor growth delayd reaction could be evaluated as an endpoint of radiation sensitivity.2.The establishment of Xenogarft model : Tumor growth was observed in 18 mice (60%, 18/30). Histologically, 15 of the18 were epithelial carcinomas similar to the original tumors, resulting in a 50% (15/30) take rate. No correlation was found between the tumor take rate and the clinicopathologic features, TP53 mutational status, or Ki67 LI of the patients' tumors. Of the 15 xenografts, 11 xenografts were passed from 3 to 10 generations. TP53 mutational status remained stable during the passages, though the Ki67 LI slightly increased in the majority of xenografts. Specific growth delay after irradiation in the 4 xenografts was observed independent of the original tumor growth speed and Ki67 LI.3.Radiological growth delay assay : To assess the usefulness of these xenografts for therapeutic simulation, we performed radiological growth-delay assay in 4 xenografts and examined the relation between the responses and the biological parameters of xenograft tumors. The radiation response considerably varied among the 4 models. Absolute growth delay ranged from 20.3+2.4 (mean+standard error) to 76.4±7.4 days. Specific growth delay (SGD) was not associated with in vivo tumor growth speed or the Ki67 Il. The smallest SGD value was observed in the No.3 model which harbored TP53 gene mutation.
期刊论文(18)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1158/1078-0432.ccr-04-0048
发表时间: 2004-06-01
期刊: CLINICAL CANCER RESEARCH
影响因子: 11.5
作者: [Tamoto, E, Tada, M, Katoh, H]
通讯作者: Katoh, H
進行性尿路上皮癌に対するTIN(Paclitaxel, Ifosfamide, Nedaplatin)療法
TIN(紫杉醇、异环磷酰胺、奈达铂)治疗晚期尿路上皮癌
DOI: --
发表时间: 2004
期刊: 癌と化学療法 31(8)
影响因子: --
作者: [鈴木 信, 篠原信雄, 他]
通讯作者:
DOI: 10.1016/j.jss.2004.06.002
发表时间: 2004-11
期刊: The Journal of surgical research
影响因子: --
作者: [M. Takada;M. Tada;Eiji Tamoto;Akiko Kawakami;Katsuhiko Murakawa;G. Shindoh;Ken-ichi Teramoto;A. Matsunaga;K. Komuro;M. Kanai;Y. Fujiwara;K. Shirata;Norihiro Nishimura;M. Miyamoto;S. Okushiba;S. Kondo;J. Hamada;H. Katoh;T. Yoshiki;T. Moriuchi]
通讯作者: M. Takada;M. Tada;Eiji Tamoto;Akiko Kawakami;Katsuhiko Murakawa;G. Shindoh;Ken-ichi Teramoto;A. Matsunaga;K. Komuro;M. Kanai;Y. Fujiwara;K. Shirata;Norihiro Nishimura;M. Miyamoto;S. Okushiba;S. Kondo;J. Hamada;H. Katoh;T. Yoshiki;T. Moriuchi
集学的治療における膀胱全摘除術と尿路変向術
多学科治疗中的根治性膀胱切除术和尿流改道术
DOI: --
发表时间: 2004
期刊: 泌尿器外科 17(2)
影响因子: --
作者: [篠原信雄, 鈴木 信, 他]
通讯作者:
6
    Discovery of diagonositc and therapeutic biomarker by circulating tumor endothelial cells in metastatic renal cell carcinoma
    • 批准号:
      23592320
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.16万
    • 财政年份:
      2011
    • 负责人:
      SHINOHARA Nobuo
    • 依托单位:
    Development of new screening system for anti-angiogenic drugs using tumor associated endothelial cells derived from renal cell carcinoma
    • 批准号:
      20591847
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2008
    • 负责人:
      SHINOHARA Nobuo
    • 依托单位:
    Establishment of gene therapy against bladder cancer utilizing gelsolin gene and a dominant negative ras mutant
    • 批准号:
      12470326
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $4.03万
    • 财政年份:
      2000
    • 负责人:
      SHINOHARA Nobuo
    • 依托单位:
    Preclinical study for gene therapy against bladder cancer utilizing gelsolin gene and a dominant negative ras mutant
    • 批准号:
      10470327
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.46万
    • 财政年份:
      1998
    • 负责人:
      SHINOHARA Nobuo
    • 依托单位:
    海外基金